CoChat

Sphingosine 1-Phosphate Receptor 4 Promotes Nonalcoholic Steatohepatitis by Activating NLRP3 Inflammasome

Open access
Hong, Chung Hwan, Ko, Myoung Seok, Kim, Jae Hyun, Cho, Hyunkyung, Lee, Chi-Ho, Yoon, Ji Eun, Yun, Ji-Young, Baek, In-Jeoung, Jang, Jung Eun, Lee, Seung Eun, Cho, Yun Kyung, Baek, Ji Yeon, Oh, Soo Jin, Lee, Bong Yong, Lim, Joon Seo, Lee, Jongkook, Hartig, Sean M., Conde de la Rosa, Laura, Garcia-Ruiz, Carmen, Lee, Ki-Up, Fernández-Checa, Jose C., Choi, Ji Woong, Kim, Sanghee, Koh, Eun Hee · 2022 · Cellular and Molecular Gastroenterology and Hepatology
Cited by 41

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Background & Aims Sphingosine 1-phosphate receptors (S1PRs) are a group of G-protein–coupled receptors that confer a broad range of functional effects in chronic inflammatory and metabolic diseases. S1PRs also may mediate the development of nonalcoholic steatohepatitis (NASH), but the specific subtypes involved and the mechanism of action are unclear. Methods We investigated which type of S1PR isoforms is activated in various murine models of NASH. The mechanism of action of S1PR4 was examined in hepatic macrophages isolated from high-fat, high-cholesterol diet (HFHCD)-fed mice. We developed a selective S1PR4 functional antagonist by screening the fingolimod (2-amino-2-[2-(4- n -octylphenyl)ethyl]-1,3- propanediol hydrochloride)-like sphingolipid-focused library. Results The livers of various mouse models of NASH as well as hepatic macrophages showed high expression of S1pr4 . Moreover, in a cohort of NASH patients, expression of S1PR4 was 6-fold higher than those of healthy controls. S1pr4 +/- mice were protected from HFHCD-induced NASH and hepatic fibrosis without changes in steatosis. S1pr4 depletion in hepatic macrophages inhibited lipopolysaccharide-mediated Ca ++ release and deactivated the Nod-like receptor pyrin domain-containning protein 3 (NLRP3) inflammasome. S1P increased the expression of S1pr4 in hepatic macrophages and activated NLRP3 inflammasome through inositol trisphosphate/inositol trisphosphate–receptor–dependent [Ca ++ ] signaling. To further clarify the biological function of S1PR4, we developed SLB736, a novel selective functional antagonist of SIPR4. Similar to S1pr4 +/- mice, administration of SLB736 to HFHCD-fed mice prevented the development of NASH and hepatic fibrosis, but not steatosis, by deactivating the NLRP3 inflammasome. Conclusions S1PR4 may be a new therapeutic target for NASH that mediates the activation of NLRP3 inflammasome in hepatic macrophages.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcmgh.2021.12.002

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 41

Metadata

Authors
Hong, C. H., Ko, M. S., Kim, J. H., Cho, H., Lee, C.-H., Yoon, J. E., Yun, J.-Y., Baek, I.-J., Jang, J. E., Lee, S. E., Cho, Y. K., Baek, J. Y., Oh, S. J., Lee, B. Y., Lim, J. S., Lee, J., Hartig, S. M., Conde de la Rosa, L., Garcia-Ruiz, C., Lee, K.-U., Fernández-Checa, J. C., Choi, J. W., Kim, S., & Koh, E. H.
Venue
Cellular and Molecular Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2022
Volume
13
Issue
3
Pages
925-947
ISSN
2352-345X (ISSN-L)
OpenAlex
W4200086865
Cited by
41
References
12
FWCI
5.06
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.